학술논문
Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19
Document Type
Article
Author
Source
In: Frontiers in Immunology . (Frontiers in Immunology, 2024, 15)
Subject
Language
English
ISSN
16643224